Iatridis E., Jenkins C.Range of usage for the Variable Prime Cobe Membrane Lung (VPCML) . Perfusion1986; 1 : 277-79.
2.
Pearson DT, McArdle B., Poslad SJ, Murray A.A clinical evaluation of the performance characteristics of one membrane and five bubble oxygenators: haemocompatibility studies. Perfusion1986; 1 : 81-98.
3.
Gourlay T., Gibbons M., Adams S., Fleming J., Taylor KMEvaluation of the Shiley M2000 membrane oxygenator. Perfusion1986; 1 : 125-134.
4.
Pearson DT, Holden MP, Poslad SJ, Murray A., Waterhouse PSA clinical evaluation of the performance characteristics of one membrane and five bubble oxygenators: gas transfer and gaseous microemboli production . Perfusion1986; 1: 15-26.
5.
Crockett JR, Grey PAThe variable Prime Cobe Membrane Lung: first impressions. Perfusion1987; 2 : 205-12.
6.
Zadeh BJ, Holazo R., Conlon C., Lazenby WD, Isom OW, Krieger KHA clinical evaluation of three modern blood oxygenators. Perfusion1987; 2 : 263-70.
7.
Sinkewich M. , Ogella D., Golding LR, Stewart R., Meserko J.Early clinical experiences with the new Bentley oxygenator system-capillary membrane (BOS-CM). Proc Am Acad Cardiovasc Perf1984; 5: 125-29.
8.
Sinkewich MR , Meserko JJ, Golding LR, Loop FDClinical evaluation of the Terumo hollow fiber membrane oxygenator. Proc Am Acad Cardiovasc Perf1982; 3: 13-16.
9.
Steward SR, Gaich-Hood PA, Fallen DM, McClosky MEDevelopment of a new hollow fiber membrane oxygenator, Part II: clinical evaluation. Proc Am Acad Cardiovasc Perf1984; 5: 118-24.
10.
Dearing JP, Crawford FC, Kratz JM, Stroud M.Clinical use of a new membrane oxygenator. JECT1984; 16: 125-29.
11.
Massimino RJ , Stearns GT, Gough JD, Martin J., Karlson K.Clinical evaluation of a microporous hollow-fiber membrane oxygenator with a large gas transfer capability. JECT1984; 16: 51-54.
12.
Zacour RKClinical evaluation of the Sarns membrane oxygenator. Perfusion1988; 3 : 219-24.
13.
Pierce EC II.The membrane versus bubble oxygenator controversy. Ann Thorac Surg1980; 29 : 497-99.
14.
Mickleborough LL, Arnold G., Chiu Rc-J.Complement consumption during cardiopulmonary bypass: bubble versus membrane oxygenators. Perfusion1986; 1 : 261-70.
15.
Boonstra PW , Vermeulen Fee, Leusink JA et al. Hematological advantage of a membrane oxygenator over bubble oxygenators in long perfusions. Ann Thorac Surg1986; 3 : 297-300.
16.
Van den Dungen Jjam, Karliczek GF, Brenken U., Homan van der Heide JN, Wildevuur Crh.Clinical study of blood trauma during perfusion with membrane and bubble oxygenators. J Thorac Cardiovasc Surg1982; 83: 108-16.
17.
Boonstra PW , Vermeulen Fee, Leusink JA et al. Platelet damage and haemolysis during bubble oxygenator perfusion with and without arterial line filter, compared to membrane oxygenator perfusion . Perfusion1987; 2 : 27-34.
18.
Edmunds LH Jr, Ellison N., Colman RW et al.Platelet function during cardiac operations. Comparison of membrane and bubble oxygenators . J Thorac Cardiovasc Surg1982; 83: 805-12.
19.
Dutton RC, Edmunds LH Jr, Hutchinson JC, Roe BBPlatelet aggregate emboli produced in patients during cardiopulmonary bypass with membrane and bubble oxygenators and blood filters. J Thorac Cardiovasc Surg1974; 67: 258-65.
20.
Boonstra PW , van Imhoff GW, Eysman L. et al. Reduced platelet activation and improved hemostasis after controlled cardiotomy suction during clinical membrane oxygenator perfusions. J Thorac Cardiovasc Surg1985; 89: 900-906.
21.
Van Deveren W., Kazatchkine MD, Deschamps-Latscha B. et al. Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation. J Thorac Cardiovasc Surg1985; 89: 888-89.
22.
Pearson DT, McArdle B.Haemocompatibility of membrane and bubble oxygenators. Perfusion1989; 4 : 9-24.
